The US Food and Drug Administration (US FDA) recently announced that it will begin hosting a new webinar series focused on showcasing alternative methods for disease modeling, efficacy, and safety, especially as applicable to US FDA regulatory reviews. The audience for this series is US FDA scientists. Those developing new methods and methodologies are invited to apply to present as part of this webinar series. Information on how to apply for the agency’s Alternative Methods Webinar Series is available on the US FDA website.
#Webinar#CollaborativeImpact